EUVIMEDOpdag EUVIMED
Open access

Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy

Rachel M Coyte, Thomas Darrah, John Olesik, Emily Barrett, Thomas G O'Connor, Jessica Brunner, Tanzy Love, Rogelio Perez-D'Gregorio, Henry Z Wang, Lauren M Aleksunes, Brian Buckley, Cathleen Doherty and 1 more

Birth Defects Research · 2023-08-15 · 115 (14) · 1264-1273

DOI: 10.1002/bdr2.2209 ↗

At a glance

Journal article in Birth Defects Research, published online on 2023-06-19. Written by Rachel M Coyte and 12 co-authors. Institution: School of Earth Sciences, The Ohio State University, Columbus, Ohio, USA. Major MEDLINE topics: Contrast Media, Gadolinium. Cited 4 times so far (Crossref); 54 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS, NIH HHS, NIEHS NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Gadolinium (Gd), a toxic rare earth element, has been shown to dissociate from chelating agents and bioaccumulate within tissues, raising concerns about the possibility of their remobilization during pregnancy with subsequent free Gd exposures to developing fetuses. Gd chelates are among the most commonly used magnetic resonance imaging (MRI) contrast agents. This investigation was undertaken after the detection of elevated Gd (800–1000× higher than the usual rare earth element levels) in preliminary unpublished studies from the placentae of subjects in the NIH ECHO/UPSIDE Rochester Cohort Study and unpublished studies from placentae analyzed in formalin‐fixed placental specimens from Surgical Pathology at the University of Rochester. Fifteen pregnancies with elevated Gd were studied (12 first pregnancies and 3 second pregnancies). Maternal bloods were collected from all three trimesters, maternal, and cord (fetal) bloods at delivery as well as placental tissue. Breastmilk was also collected from selected mothers. It was determined that Gd was present in maternal bloods from all three trimesters, and in cord bloods and breastmilk in both first and second pregnancies. These results emphasize the need to fully appreciate the implications of pre‐pregnancy exposure to Gd chelates and its potential effects on maternal and fetal health.

Subjects

MeSH terms (MEDLINE)

Contrast MediaGadoliniumHumansFemalePregnancyPlacentaCohort StudiesChelating AgentsMothersGravidity

Author keywords

breastmilkgadoliniumhumanmaternal and cord bloodspharmacokineticsplacentapregnancy

Substances

Contrast MediaGadoliniumChelating Agents

Authors and institutions

  • School of Earth Sciences, The Ohio State University, Columbus, Ohio, USA.
  • Global Water Institute, The Ohio State University, Columbus, Ohio, USA.
  • Department of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Department of Biostatistics and Epidemiology, Rutgers School of Public Health; Environmental and Occupational Health Sciences Institute, Piscataway, New Jersey, USA.
  • Department of Psychiatry, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA.
  • Department of Neuroscience, University of Rochester, School of Medicine and Dentistry, Rochester, New York, USA.

ORCID profiles: Richard K Miller

Funding

  • NICHD NIH HHS
  • NIH HHS
  • NIEHS NIH HHS
  • National Institutes of Health

Cite

APA

Coyte, R. M., Darrah, T., Olesik, J., Barrett, E., O'Connor, T. G., Brunner, J., Love, T., Perez-D'Gregorio, R., Wang, H. Z., Aleksunes, L. M., Buckley, B., Doherty, C., & Miller, R. K. (2023). Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy. Birth Defects Research, 115(14), 1264-1273. https://doi.org/10.1002/bdr2.2209

Vancouver

Coyte RM, Darrah T, Olesik J, Barrett E, O'Connor TG, Brunner J, et al. Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy. Birth Defects Research. 2023;115(14):1264-1273. doi:10.1002/bdr2.2209

BibTeX
@article{Coyte2023,
  author = {Coyte, Rachel M and Darrah, Thomas and Olesik, John and Barrett, Emily and O'Connor, Thomas G and Brunner, Jessica and Love, Tanzy and Perez-D'Gregorio, Rogelio and Wang, Henry Z and Aleksunes, Lauren M and Buckley, Brian and Doherty, Cathleen and Miller, Richard K},
  title = {Gadolinium during human pregnancy following administration of gadolinium chelate before pregnancy},
  journal = {Birth Defects Research},
  year = {2023},
  volume = {115},
  number = {14},
  pages = {1264--1273},
  doi = {10.1002/bdr2.2209}
}
Start for free →